This webinar recording features a panel discussion on how growth in RNA-based drug development adds complexities to IP management that can put your investments in new products at risk and lead to future legal conflicts.
View Video https://cas.sherpadm.com/client/player/3b514cb7-41a4-44ea-b519-bf90946b8396
Language